iBio, Inc. (IBIO) stock
IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.73−0.03 (-4.00%)
Close on Nov 13, 2026Market cap $47.05MP/E –Yield –
iBio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
iBio's enterprise value was -$42.13M on Nov 11, 2026, against -$24.90M a year earlier. Over the last 5 years it ranged from -$45.22M to $70.67M, with a median of $3.33M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$42.13M | – |
| 2025 | Dec 31, 2025 | -$10.72M | -201.0% |
| 2024 | Dec 31, 2024 | $10.61M | – |
| 2023 | Dec 29, 2023 | -$2.87M | – |
| 2022 | Dec 30, 2022 | -$11.92M | -128.1% |
| 2021 | Dec 31, 2021 | $42.41M | -62.1% |
| 2020 | Dec 31, 2020 | $112.02M | +2751.7% |
| 2019 | Dec 31, 2019 | $3.93M | -29.7% |
| 2018 | Dec 31, 2018 | $5.59M | -48.2% |
| 2017 | Dec 29, 2017 | $10.79M | -62.9% |
| 2016 | Dec 30, 2016 | $29.10M | -16.7% |
| 2015 | Dec 31, 2015 | $34.92M | -18.9% |
| 2014 | Dec 31, 2014 | $43.06M | +172.0% |
| 2013 | Dec 31, 2013 | $15.83M | -37.5% |
| 2012 | Dec 31, 2012 | $25.34M | -0.1% |
| 2011 | Dec 30, 2011 | $25.35M | – |
See a number that looks wrong?